Produced by Lucy Verde
Since January 22, 2004, SICOR became Teva’s affiliate. This acquisition brought together two top-level generic drug producers, combining Teva’s success at marketing oral ingested products, and Sicor’s leadership in injections. Also, the synergy between SICOR’s pharmaceuticals and biogeneric drug production increased the line of offered products for the company.
Later, on January 26, 2006, acquisition of the IVAX Corporation was completed. IVAX conducts research, development, production and marketing for branded generics and veterinary products in the United States and abroad. IVAX brought along its strong presence in Latin America, Central and Eastern Europe, as well as other business endeavors in North America and the rest of Europe. Other product lines carried by IVAX include generic drugs for the respiratory system and products under development for oncology and CNS treatments. The affiliation of both companies brought a wider product portfolio, thus improving the cost-effect outcome both for generics as well as in branded products.
In 2011, Teva bought Theramex, an European company run by Merck KGaA specialized in women’s health, which broadened Teva’s reach into gynecological products, which are available in more than 50 countries.
Teva’s activity in Japan increased after the acquisitions of Tayio and KOWA, in July and September 2011, respectively, reinforcing the company’s presence in the Asian country’s generics market.
Previously on May 2011, Cephalon was acquired along with its worldwide affiliates. The transaction brought a long-term strategy for Teva to grow its farmacopea both with branded products as well as with pharmaceutical specialties.
A joint venture between Teva and Procter & Gamble back in September 2011 created PGT Healthcare, a global company focused in developing the best non-prescription brand medicine.
Until now, Teva’s shares trade high in the Tel Aviv Stock Exchange, and it is also one of Israel’s largest spreads in NASDAQ. Teva’s stocks are also traded in London’s SEAQ and in the Frankfurt Stock Exchange.
Innovation and thriving for improvement in the generic drugs field is now part of the company’s DNA and everyday chores. During the last few years, Teva launched new treatments for diseases such as Parkinson’s and multiple-sclerosis; and the optimization of a formula for the treatment of osteoporosis is a current goal. One of the company’s most important concerns is product quality.
Also, TP Mexico offers treatment and therapy for most common diseases, their generics catalogue includes more than 220 entries in 185 assorted pharmaceuticals, presented in different formulations.
Generic drugs produced at Teva’s two facilities in Mexico, and their commercialization brought more than $100 million in revenue. Starting on 2015, the company is seeking a 10 percent yearly growth, mainly from new product manufacturing in their Lerma plant, near Toluca, capital of the State of Mexico.
To be continued in the next edition of Healthcare Global…
Driving healthcare innovation through data and analytics
Legacy Community Health: digitally enabling patient care
Mediterraneo Hospital: Transforming procurement via tech
Cerner Middle East: the journey to healthcare transformation
The Mental Health Center of Denver: The human side of tech
Kettering Health Network’s strategic digital transformation
LTTS: Healthcare tech to navigate the new normal
Northwell Health: Data-driven transformation in healthcare
MED-EL: digital transformation for quality of life
Leumit Health Services: Digital transformation of patient care
How GE Healthcare has harnessed digital technology to transform itself and the world around it
How Allscripts is driving the future of healthcare IT
Diagnostic Services Manitoba: Providing the results that matter
CHRISTUS Health’s digital transformation reimagines healthcare technology and IT
Taiba Hospital: Patient care with promise
Ottawa Hospital: Transforming health care from the inside out
MyHealth Centre: Quality patient experience
American Hospital, Dubai: supporting collaboration within healthcare
How Manipal Health Enterprises has proven that its abilities match its ambitions
Apollo Hospitals: Personalizing healthcare with technology